Recent News

• 03.19.2026 - Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
• 03.11.2026 - Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
• 03.06.2026 - Solid Biosciences Announces Oversubscribed $240 Million Private Placement
• 03.02.2026 - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 03.12.2026 - 8-K Current report
• 03.11.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.10.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 03.10.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 03.06.2026 - 8-K Current report
• 02.18.2026 - 144 Report of proposed sale of securities
• 02.18.2026 - 144 Report of proposed sale of securities
• 02.18.2026 - 144 Report of proposed sale of securities
• 02.18.2026 - 4 Statement of changes in beneficial ownership of securities